Innate Pharma (Portfolio of Transglutaminase Patents in Marseille, France) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Innate Pharma (Portfolio of Transglutaminase Patents in Marseille, France) General Information

Description

Portfolio of transglutaminase patents for the generation of Antibody-Drug Conjugates. The patents related to its ADC transglutaminase conjugation technology.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Marseille
  • France
Primary Industry
Buildings and Property
Other Industries
Other Healthcare
Acquirer
Corporate Office
  • Marseille
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Innate Pharma (Portfolio of Transglutaminase Patents in Marseille, France) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Innate Pharma (Portfolio of Transglutaminase Patents in Marseille, France)‘s full profile, request access.

Request a free trial

Innate Pharma (Portfolio of Transglutaminase Patents in Marseille, France) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Innate Pharma (Portfolio of Transglutaminase Patents in Marseille, France)‘s full profile, request access.

Request a free trial

Innate Pharma (Portfolio of Transglutaminase Patents in Marseille, France) FAQs

  • Where is Innate Pharma (Portfolio of Transglutaminase Patents in Marseille, France) headquartered?

    Innate Pharma (Portfolio of Transglutaminase Patents in Marseille, France) is headquartered in Marseille, France.

  • What industry is Innate Pharma (Portfolio of Transglutaminase Patents in Marseille, France) in?

    Innate Pharma (Portfolio of Transglutaminase Patents in Marseille, France)’s primary industry is Buildings and Property.

  • Is Innate Pharma (Portfolio of Transglutaminase Patents in Marseille, France) a private or public company?

    Innate Pharma (Portfolio of Transglutaminase Patents in Marseille, France) is a Private company.

  • What is Innate Pharma (Portfolio of Transglutaminase Patents in Marseille, France)’s current revenue?

    The current revenue for Innate Pharma (Portfolio of Transglutaminase Patents in Marseille, France) is .

  • Who are Innate Pharma (Portfolio of Transglutaminase Patents in Marseille, France)’s investors?

    Innate Pharma has invested in Innate Pharma (Portfolio of Transglutaminase Patents in Marseille, France).

  • When was Innate Pharma (Portfolio of Transglutaminase Patents in Marseille, France) acquired?

    Innate Pharma (Portfolio of Transglutaminase Patents in Marseille, France) was acquired on 24-Sep-2024.

  • Who acquired Innate Pharma (Portfolio of Transglutaminase Patents in Marseille, France)?

    Innate Pharma (Portfolio of Transglutaminase Patents in Marseille, France) was acquired by Araris.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process